• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷胱甘肽过氧化物酶3通过NrF2/NF-κB途径拮抗糖尿病视网膜病变中的氧化应激和炎症。

Glutathione peroxidase 3 antagonizes oxidative stress and inflammation in diabetic retinopathy via NrF2/NF-κB pathway.

作者信息

Qiao Manrong, Zhang Lei, Wu Yiting, Ma Bo

机构信息

Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, 710004, China.

出版信息

Int Ophthalmol. 2025 Jun 6;45(1):231. doi: 10.1007/s10792-025-03582-7.

DOI:10.1007/s10792-025-03582-7
PMID:40478328
Abstract

PURPOSE

Hyperglycemia-oxidative stress (OS)-inflammation-apoptosis cascade reaction is an important pathogenesis of diabetes retinopathy (DR). However, the function of glutathione peroxidase 3 (GPX3), an important antioxidant molecule, in the pathogenesis of DR remains unclear. This study aims to explore the function and mechanism of GPX3 mediated OS in the occurrence and development of DR.

METHODS

Human retinal capillary endothelial cells (HRCECs) were cultured in vitro to construct a high glucose environment, GPX3 deficiency, and GPX3 overexpression HRCEC cell model. Cell proliferation activity, OS level, inflammation, apoptosis, and NrF2/NF-κB pathway expression were detected by CCK-8 assay, qRT-PCR, Western blot, and flow cytometry.

RESULTS

The high glucose treatment resulted in a time and dose dependent decrease in the proliferation activity and GPX3 expression level of HRCECs, and promoted the occurrence of cell OS, inflammation, and apoptosis. At the same time, it inhibited the expression of nuclear factor erythroid 2-related factor 2 (NrF2) and up-regulated the expression of nuclear factor kappa B (NF-κB); The down-regulation of GPX3 expression exacerbated the effects of high glucose environment on the OS, inflammation, apoptosis, and NrF2/NF-κB pathway of HRCECs, while overexpression of GPX3 can partially antagonize the effects of high glucose environment on the OS, inflammation, apoptosis, and NrF2/NF-κB pathway of HRCECs.

CONCLUSIONS

Targeted regulation of GPX3, which is down-regulated and inactivated in DR, is expected to mediate the occurrence and development of OS, inflammation, and cell apoptosis in DR through the NrF2/NF-κB pathway.

摘要

目的

高血糖-氧化应激(OS)-炎症-凋亡级联反应是糖尿病视网膜病变(DR)的重要发病机制。然而,重要的抗氧化分子谷胱甘肽过氧化物酶3(GPX3)在DR发病机制中的作用仍不清楚。本研究旨在探讨GPX3介导的OS在DR发生发展中的作用及机制。

方法

体外培养人视网膜毛细血管内皮细胞(HRCECs),构建高糖环境、GPX3缺陷及GPX3过表达的HRCEC细胞模型。采用CCK-8法、qRT-PCR、Western blot和流式细胞术检测细胞增殖活性、OS水平、炎症、凋亡及NrF2/NF-κB通路表达。

结果

高糖处理导致HRCECs增殖活性和GPX3表达水平呈时间和剂量依赖性下降,并促进细胞OS、炎症和凋亡的发生。同时,抑制核因子红细胞2相关因子2(NrF2)的表达,上调核因子κB(NF-κB)的表达;GPX3表达下调加剧了高糖环境对HRCECs的OS、炎症、凋亡及NrF2/NF-κB通路的影响,而GPX3过表达可部分拮抗高糖环境对HRCECs的OS、炎症、凋亡及NrF2/NF-κB通路的影响。

结论

靶向调控在DR中下调失活的GPX3,有望通过NrF2/NF-κB通路介导DR中OS、炎症及细胞凋亡的发生发展。

相似文献

1
Glutathione peroxidase 3 antagonizes oxidative stress and inflammation in diabetic retinopathy via NrF2/NF-κB pathway.谷胱甘肽过氧化物酶3通过NrF2/NF-κB途径拮抗糖尿病视网膜病变中的氧化应激和炎症。
Int Ophthalmol. 2025 Jun 6;45(1):231. doi: 10.1007/s10792-025-03582-7.
2
C1q/tumor necrosis factor-related protein-3 (CTRP3) activated by forkhead box O4 (FOXO4) down-regulation protects retinal pericytes against high glucose-induced oxidative damage through nuclear factor erythroid 2-related factor 2 (Nrf2)/Nuclear factor-kappaB (NF-κB) signaling.叉头框蛋白 O4(FOXO4)下调激活的 C1q/肿瘤坏死因子相关蛋白-3(CTRP3)通过核因子红细胞 2 相关因子 2(Nrf2)/核因子-κB(NF-κB)信号通路保护高糖诱导的视网膜周细胞氧化损伤。
Bioengineered. 2022 Mar;13(3):6080-6091. doi: 10.1080/21655979.2022.2031413.
3
Platycodin D inhibits diabetic retinopathy via suppressing TLR4/MyD88/NF-κB signaling pathway and activating Nrf2/HO-1 signaling pathway.桔梗皂苷 D 通过抑制 TLR4/MyD88/NF-κB 信号通路和激活 Nrf2/HO-1 信号通路来抑制糖尿病视网膜病变。
Chem Biol Drug Des. 2024 Jan;103(1):e14419. doi: 10.1111/cbdd.14419.
4
Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression.骨髓间充质干细胞诱导的外泌体微小RNA-486-3p通过抑制TLR4/NF-κB轴预防糖尿病视网膜病变。
J Endocrinol Invest. 2021 Jun;44(6):1193-1207. doi: 10.1007/s40618-020-01405-3. Epub 2020 Sep 26.
5
Growth Arrest-specific 1 Inhibits Keap1/Nrf2 Signaling Transduction in the Activation of the Ferroptosis Program in Retinal Müller Cells.生长停滞特异性蛋白1在视网膜穆勒细胞铁死亡程序激活中抑制Keap1/Nrf2信号转导
Front Biosci (Landmark Ed). 2025 Mar 18;30(3):27954. doi: 10.31083/FBL27954.
6
polysaccharide inhibits high glucose-induced oxidative stress, inflammatory response, and apoptosis in RPE cells.多糖可抑制高糖诱导的视网膜色素上皮(RPE)细胞氧化应激、炎症反应和细胞凋亡。
J Recept Signal Transduct Res. 2022 Apr;42(2):189-196. doi: 10.1080/10799893.2021.1883061. Epub 2021 Feb 8.
7
Long Noncoding RNA MEG3 Inhibits Apoptosis of Retinal Pigment Epithelium Cells Induced by High Glucose via the miR-93/Nrf2 Axis.长链非编码 RNA MEG3 通过 miR-93/Nrf2 轴抑制高糖诱导的视网膜色素上皮细胞凋亡。
Am J Pathol. 2020 Sep;190(9):1813-1822. doi: 10.1016/j.ajpath.2020.05.008. Epub 2020 May 28.
8
Carvedilol activates nuclear factor E2-related factor 2/ antioxidant response element pathway to inhibit oxidative stress and apoptosis of retinal pigment epithelial cells induced by high glucose.卡维地洛通过激活核因子 E2 相关因子 2/抗氧化反应元件通路抑制高糖诱导的视网膜色素上皮细胞氧化应激和细胞凋亡。
Bioengineered. 2022 Jan;13(1):735-745. doi: 10.1080/21655979.2021.2012627.
9
Astaxanthin inhibits oxidative stress and apoptosis in diabetic retinopathy.虾青素抑制糖尿病视网膜病变中的氧化应激和细胞凋亡。
Acta Histochem. 2023 Aug;125(6):152069. doi: 10.1016/j.acthis.2023.152069. Epub 2023 Jun 19.
10
DJ-1 protects retinal pericytes against high glucose-induced oxidative stress through the Nrf2 signaling pathway.DJ-1 通过 Nrf2 信号通路保护视网膜周细胞免受高糖诱导的氧化应激。
Sci Rep. 2020 Feb 12;10(1):2477. doi: 10.1038/s41598-020-59408-2.

本文引用的文献

1
NRF2 in age-related musculoskeletal diseases: Role and treatment prospects.NRF2在年龄相关性肌肉骨骼疾病中的作用及治疗前景
Genes Dis. 2023 Nov 27;11(6):101180. doi: 10.1016/j.gendis.2023.101180. eCollection 2024 Nov.
2
A drug delivery system of siRNA nanoparticles loaded by mesenchymal stem cells on choroidal neovascularization.载有间充质干细胞的 siRNA 纳米粒药物输送系统治疗脉络膜新生血管
Nanomedicine (Lond). 2024;19(26):2171-2185. doi: 10.1080/17435889.2024.2393075. Epub 2024 Sep 3.
3
Circular RNA Circ_0122396 Regulates Human Lens Epithelial Cell Progression by Regulating miR-23a-3p and MMP16 in Age-Related Cataract.
环状 RNA Circ_0122396 通过调节 miR-23a-3p 和 MMP16 来调控年龄相关性白内障中人晶状体上皮细胞的进展。
Curr Eye Res. 2024 Nov;49(11):1161-1170. doi: 10.1080/02713683.2024.2374841. Epub 2024 Jul 5.
4
The role of Keap1-Nrf2 signaling pathway during the progress and therapy of diabetic retinopathy.Keap1-Nrf2 信号通路在糖尿病视网膜病变进展和治疗中的作用。
Life Sci. 2024 Feb 1;338:122386. doi: 10.1016/j.lfs.2023.122386. Epub 2023 Dec 28.
5
A correlation between oxidative stress and diabetic retinopathy: An updated review.氧化应激与糖尿病视网膜病变的相关性:最新综述。
Exp Eye Res. 2023 Nov;236:109650. doi: 10.1016/j.exer.2023.109650. Epub 2023 Sep 19.
6
Research progress on the pathogenesis of diabetic retinopathy.糖尿病视网膜病变发病机制的研究进展。
BMC Ophthalmol. 2023 Sep 11;23(1):372. doi: 10.1186/s12886-023-03118-6.
7
Oxidatively stressed extracellular microenvironment drives fibroblast activation and kidney fibrosis.氧化应激的细胞外微环境驱动成纤维细胞活化和肾脏纤维化。
Redox Biol. 2023 Nov;67:102868. doi: 10.1016/j.redox.2023.102868. Epub 2023 Sep 1.
8
Mechanisms of Nrf2 and NF-κB pathways in diabetic wound and potential treatment strategies.Nrf2 和 NF-κB 通路在糖尿病创面中的作用机制及潜在治疗策略。
Mol Biol Rep. 2023 Jun;50(6):5355-5367. doi: 10.1007/s11033-023-08392-7. Epub 2023 Apr 8.
9
The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.炎症在糖尿病性视网膜病变免疫中的作用:分子机制、发病作用和治疗意义。
Front Immunol. 2022 Dec 13;13:1055087. doi: 10.3389/fimmu.2022.1055087. eCollection 2022.
10
Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.氧化应激与糖尿病视网膜病变:分子机制、发病作用及治疗意义。
Redox Biol. 2020 Oct;37:101799. doi: 10.1016/j.redox.2020.101799. Epub 2020 Nov 13.